M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.91 USD -3.54% Market Closed
Market Cap: 90.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

Wall Street
Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 8.61 USD with a low forecast of 4.24 USD and a high forecast of 15.75 USD.

Lowest
Price Target
4.24 USD
122% Upside
Average
Price Target
8.61 USD
351% Upside
Highest
Price Target
15.75 USD
725% Upside
MDxHealth SA Competitors:
Price Targets
SGMT
Sagimet Biosciences Inc
460% Upside
MAAT
Maat Pharma SA
97% Upside
CYTK
Cytokinetics Inc
50% Upside
688278
Xiamen Amoytop Biotech Co Ltd
2% Downside
6160
Beigene Ltd
16% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
21% Upside
ACLX
Arcellx Inc
7% Downside
INO
Inovio Pharmaceuticals Inc
212% Upside

Revenue
Forecast

Revenue Estimate
MDxHealth SA

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 3 years is 20%.

19%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
MDxHealth SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXH's stock price target?
Price Target
8.61 USD

According to Wall Street analysts, the average 1-year price target for MDXH is 8.61 USD with a low forecast of 4.24 USD and a high forecast of 15.75 USD.

What is MDxHealth SA's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 3 years is 20%.

Back to Top